PKD Foundation leads the fight against PKD through vital research funding and patient education. Now drug therapies in cardiovascular health, Rapamycin, Somatostatin, Tolvaptan, Triptolide, and water therapies offer help and hope to the 12.5 million worldwide with PKD.